Dermatology is thriving with innovation, from smart oral drugs to gene-therapy based fixes for rare skin diseases and skin ...

The complex and costly journey of oncology drug development is reliant on robust and comprehensive clinical data. Early-stage ...

The US FDA has granted approval for Roche's Gazyva/ Gazyvaro to treat adult patients with active LN who are on standard ...

The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare ...

J&J will now explore Rybrevant's efficacy and safety in a Phase III trial in first-line, EGFR-driven HNSCC and colorectal ...

Sanofi’s teplizumab, which is already FDA-approved to delay the onset of stage 3 type 1 diabetes, has been included on the ...

The US Food and Drug Administration’s (FDA) recent clearance of Roche’s blood-based Alzheimer’s disease test will boost ...

These Phase III results could enhance uptake of Eli Lilly's Verzenio alongside ET in the adjuvant breast cancer setting, if ...

A&O Shearman and CMS have emerged as the top legal advisers in terms of deal value and deal volume, respectively.

Wachtell, Lipton, Rosen & Katz and Kirkland & Ellis have emerged as the top M&A legal advisers in North America in terms of ...

Paul Hastings and TriLegal have emerged as the leading mergers and acquisitions (M&A) legal advisers in the Asia-Pacific ...

Goldman Sachs and Houlihan Lokey have emerged as the leading mergers and acquisitions (M&A) financial advisers in North ...